Recent Research Funding

Strong funding from many sources supports research in our division.

Backed by grants from foundations, institutes, companies, programs and organizations, our physician-scientists engage in various areas of research and conduct innovative studies.

We’ve received competitively awarded funding from sources such as:

  • National Institutes of Health
  • GlaxoSmithKline
  • United States Department of Veterans Affairs
  • National Kidney Foundation
  • Arthritis Foundation
  • NephroGenex, Inc.
  • Agency for Healthcare Research and Quality
  • Amgen
  • R01 DK114485 Computational Imaging of Renal Structures for Diagnosing Diabetic Nephropathy. Rabi Yacoub (Co-Investigator). National Institutes of Health (NIH) NIDDK/NIH. $993,750. 9/1/2018-7/1/2023.
  • Utilization of Renin Angiotensin Aldosterone System Inhibitors in Patients with Heart Failure and/or Diabetic Nephropathy. Shirley Chang (Principal Investigator). NHLBI 5K12HL138052-2. 9/1/2018-8/1/2022.
  • Looking for Answers to the COVID-19 Pandemic: Turning the tide on COVID-19 by understanding nutritional factors and using medication repurposing. Shirley Chang (Co-Investigator). 4/1/2020-8/5/2021.
  • Age and Race Influences on Immunosuppression After Renal Transplant. Shirley Chang (Contributor). NIH. 5/1/2019-8/5/2021.
  • Observation Study to Analyze Wuality of Care for Chronic Kidney Disease Using Data from 1.3 million Patients from the Instutue for Healthcare Informatics IHI at University of Buffalo. Shirley Chang (Principal Investigator). 2/1/2018-8/5/2021.
  • Enhanced Recovery after Surgery (ERAS): New Paradigm for Organ Transplantation. Shirley Chang (Contributor). 11/1/2017-8/5/2021.
  • Evaluatio of Patients Outcomes from the Kidney Allograft Outcome Allosure Registry. Shirley Chang (Contributor). 2/1/2019-8/5/2021.
  • NIH R01. Jessy Alexander (Principal Investigator). National Institute of Health. $717,750. 7/1/2018-7/1/2021.
  • Computational analysis of neutrophil extracellular traps in lupus nephritis renal biopsies. Rabi Yacoub (Co-Investigator). NIDDK/NIH, CKD Biomarkers Consortium BioCon Pilot Studies. $50,000. 7/1/2019-6/1/2020.
  • Real-Time Dynamics of Drug-Induced Nephrotoxicity. Rabi Yacoub (Co-Investigator). Clinical and Translational Science Institute Pilot studies. $50,000. 4/1/2019-3/1/2020.
  • American Hearing Research Foundation. Jessy Alexander (Principal Investigator). American Hearing Research Foundation. $20,000. 1/1/2018-12/1/2018.